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Background
For a therapeutic HIV-1 vaccine, it should be considered
that the immune system has been confronted with a cer-
tain viral sequence and mounted CD8 T cell responses
specifically towards the infecting virus. One question is
whether the immune system of HIV-infected individuals
can create a new response towards a variant epitope in
the case of vaccination. To study this in a comparable
setting, we addressed the question how frequently a new
CD8 T cell response can be generated after the occur-
rence of a viral escape mutation in its recognized epitope
in a population not selected for a certain HLA allele.
Methods
19 HIV-infected untreated subjects were sampled longitud-
inally (>6 months. We searched for CD8 T cell responses
that declined over the course of untreated infection and
sequenced the autologous virus of the early and late time
point by RT-PCR. Recognition of wildtype and newly aris-
ing sequences was compared in peptide titration assays.
Results
A total of 30 declining CD8 T cell responses were studied
in detail and viral sequence analyses showed amino acid
changes in 25 (83%) of these. Peptide titration assays
revealed 12 (48%) viral escape mutations with 2 de-novo
responses (17%). Here the de-novo response showed less
effector functions than the original CD8 T cell response.
In addition we identified 5 (20%) shifts in immunodomi-
nance. None of the subjects with adaptation to the chan-
ging virus carried the HLA alleles B27, B57 or B*5801.
Conclusion
Our results show that CD8 T cell responses can adapt to
the mutations of HIV. However it was limited to only 28%
(7 out of 25) of cases in a cohort not expressing protective
HLA alleles.
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